Latham & Watkins represented the underwriters in the offering. Eliem Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to...
You must be a Standard 1 Year member to access this content.
Cahill represented the initial purchasers in the offering. Akumin Escrow Inc. executed its offering of $375,000,000 aggregate principal amount of 7.500% senior secured notes due 2028 (whose obligations...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling advised the underwriters in the offering. Caribou Biosciences, Inc. executed its initial public offering of 19 million shares of common stock at a public...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering. Theravance Biopharma, Inc. executed its $100.5 million public offering of ordinary shares. Theravance Biopharma’s ordinary shares are listed on the Nasdaq...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Century Therapeutics, Inc. executed the $242.7 million initial public offering of 12,132,500 shares of...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. with a $143.7 million SEC-registered follow-on offering of 4,356,060 shares of...
You must be a Standard 1 Year member to access this content.
Homburger advised Molecular Partners AG in the transaction, while Davis Polk and Advestra advised the joint book-running managers and representatives of the underwriters. Molecular Partners AG,...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offerings. SVB Financial Group executed its offerings of $500 million aggregate principal...
You must be a Standard 1 Year member to access this content.
Conyers and Davis Polk & Wardwell is advising Roivant Sciences Ltd., in its business combination by merger of a subsidiary with Montes Archimedes Acquisition Corp. (MAAC)...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represents the underwriters in the offering while Wilson Sonsini Goodrich & Rosati advised Reneo Pharmaceuticals, Inc. Reneo Pharmaceuticals, Inc. has announced the pricing...
You must be a Standard 1 Year member to access this content.
Cravath represented the initial purchasers in the offering. Magnite executed its $400 million 144A/Reg. S convertible senior notes offering. The transaction closed on March 18, 2021. The Initial Purchasers included Goldman Sachs &...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the offering. SVB Financial Group executed its $1 billion public offering of common...
You must be a Standard 1 Year member to access this content.
